| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.171 | - | - | - | 45.461 | 38.337 | 52.006 | 57.048 | 56.293 | 52.092 |
| Total Income - EUR | 19.171 | - | - | - | 59.206 | 43.524 | 52.006 | 57.048 | 56.293 | 52.174 |
| Total Expenses - EUR | 18.409 | - | - | - | 52.814 | 37.930 | 55.621 | 74.584 | 69.113 | 81.298 |
| Gross Profit/Loss - EUR | 762 | - | - | - | 6.392 | 5.594 | -3.615 | -17.535 | -12.820 | -29.124 |
| Net Profit/Loss - EUR | 187 | - | - | - | 5.938 | 5.210 | -4.135 | -18.106 | -13.383 | -30.690 |
| Employees | 6 | - | - | - | 5 | 3 | 0 | 5 | 5 | 4 |
Check the financial reports for the company - Policlinica Solaris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 213.806 | - | - | - | 119.144 | 111.659 | 105.508 | 102.181 | 98.205 | 94.009 |
| Current Assets | 807 | - | - | - | 2.651 | 3.656 | 3.272 | 5.345 | 4.453 | 8.147 |
| Inventories | 0 | - | - | - | 0 | 0 | 895 | 897 | 895 | 948 |
| Receivables | 0 | - | - | - | 341 | 2.220 | 2.171 | 2.178 | 1.844 | 3.901 |
| Cash | 807 | - | - | - | 2.310 | 1.436 | 206 | 2.270 | 1.714 | 3.298 |
| Shareholders Funds | -36.546 | - | - | - | -36.227 | -30.330 | -33.793 | -52.004 | -65.780 | -96.102 |
| Social Capital | 45 | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 110.467 | - | - | - | 125.042 | 116.591 | 114.163 | 132.046 | 141.038 | 171.010 |
| Income in Advance | 140.692 | - | - | - | 32.980 | 29.054 | 28.410 | 28.498 | 28.411 | 28.253 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Policlinica Solaris Srl